PRIMARY EFFUSION LYMPHOMA
Clinical trials for PRIMARY EFFUSION LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new PRIMARY EFFUSION LYMPHOMA trials appear
Sign up with your email to follow new studies for PRIMARY EFFUSION LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to boost immune attack on tough lymphomas
Disease control OngoingThis phase 2 trial tests whether adding varlilumab to nivolumab helps people with aggressive B-cell lymphomas that have returned or not responded to standard therapy. About 54 participants will receive either nivolumab alone or nivolumab plus varlilumab. The goal is to see if the…
Matched conditions: PRIMARY EFFUSION LYMPHOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 11, 2026 20:40 UTC
-
Hidden risk: HIV patients with rare cancers face faster bone loss
Knowledge-focused OngoingThis study looks at why people with HIV and certain cancers (like Kaposi sarcoma) may lose bone density faster. Researchers will review past CT scans from 40 adults treated at the NIH between 2005 and 2020. The goal is to find factors linked to bone loss, which can help improve f…
Matched conditions: PRIMARY EFFUSION LYMPHOMA
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 26, 2026 04:24 UTC